Lymphoepithelioma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (NCT01956084) | Catherine Bollard | 2013-11-01 |
| LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (NCT00062868) | Baylor College of Medicine | 2003-09-01 |
Track Lymphoepithelioma automatically
Every clearance here is in the API, with alerts when new ones post.